Pro Medicus share price drops again as insiders buy — what ASX:PME traders watch next
Pro Medicus shares fell 2.35% to A$123.00 Wednesday, extending a 43% drop for 2026 despite the S&P/ASX 200 closing higher. Directors Anthony Glenning and Deena Shiff bought shares on Feb. 13. The company reported half-year revenue of A$124.8 million and statutory profit after tax of A$171.2 million, boosted by a fair-value gain. Pro Medicus declared a 32-cent interim dividend, ex-dividend Feb. 26, payable March 20.
